User profiles for Pieter Postmus

Pieter Postmus

LUMC
Verified email at lumc.nl
Cited by 49688

[HTML][HTML] The IASLC Lung Cancer Staging Project: proposals for the revision of the TNM stage groupings in the forthcoming (seventh) edition of the TNM Classification …

…, PA Groome, R Rami-Porta, PE Postmus… - Journal of thoracic …, 2007 - Elsevier
Introduction The seventh edition of the TNM Classification of Malignant Tumors is due to be
published early in 2009. In preparation for this, the International Association for the Study of …

[HTML][HTML] Prophylactic cranial irradiation in extensive small-cell lung cancer

…, E Rankin, M Snee, M Hatton, P Postmus… - … England Journal of …, 2007 - Mass Medical Soc
Background We conducted a randomized trial of prophylactic cranial irradiation in patients
with extensive small-cell lung cancer who had had a response to chemotherapy. Methods …

Effectiveness of positron emission tomography in the preoperative assessment of patients with suspected non-small-cell lung cancer: the PLUS multicentre …

…, P Verboom, JC van Mourlk, PE Postmus… - The Lancet, 2002 - thelancet.com
Background Up to 50% of curative surgery for suspected non-small-cell lung cancer is
unsuccessful. Accuracy of positron emission tomography (PET) with 18-fluorodeoxyglucose ( 18 …

Prognostic value of right ventricular mass, volume, and function in idiopathic pulmonary arterial hypertension

…, MD Spreeuwenberg, PE Postmus… - European heart …, 2007 - academic.oup.com
Aims This study investigated the relationship between right ventricular (RV) structure and
function and survival in idiopathic pulmonary arterial hypertension (IPAH). Methods and results …

Prognostic factors in patients with pleural mesothelioma: the European Organization for Research and Treatment of Cancer experience.

…, P Therasse, J van Meerbeeck, PE Postmus… - Journal of Clinical …, 1998 - ascopubs.org
PURPOSE Identification of prognostic factors in patients with malignant pleural mesothelioma
based on prospectively collected international data. PATIENTS AND METHODS From …

[HTML][HTML] The International Association for the Study of Lung Cancer lung cancer staging project: proposals regarding the clinical staging of small cell lung cancer in the …

…, J Crowley, P Van Houtte, PE Postmus… - Journal of thoracic …, 2007 - Elsevier
Background Small cell lung cancer (SCLC) is usually classified using the limited and extensive
definition. The tumor, node, metastasis (TNM) classification should also be applicable to …

[HTML][HTML] The IASLC Lung Cancer Staging Project: proposals regarding the relevance of TNM in the pathologic staging of small cell lung cancer in the forthcoming …

…, J Crowley, P Van Houtte, PE Postmus… - Journal of thoracic …, 2009 - Elsevier
Introduction For more than 50 years, small cell lung cancer (SCLC) has been staged mainly
as either limited or extensive stage disease. Small published series of resected SCLC have …

Topotecan, a new active drug in the second-line treatment of small-cell lung cancer: a phase II study in patients with refractory and sensitive disease. The European …

…, T Gamucci, S Kaplan, P Postmus… - Journal of clinical …, 1997 - ascopubs.org
PURPOSE To assess activity and toxicity of topotecan in previously treated small-cell lung
cancer (SCLC) patients. PATIENTS AND METHODS Patients with measurable SCLC, …

Noninvasively assessed pulmonary artery stiffness predicts mortality in pulmonary arterial hypertension

…, A Becker, JWR Twisk, A Boonstra, PE Postmus… - Chest, 2007 - Elsevier
Aims: Decreased total compliance of the pulmonary vascular bed is associated with increased
mortality in patients with pulmonary arterial hypertension (PAH). We investigated whether …

[PDF][PDF] Rapid decrease in delivery of chemotherapy to tumors after anti-VEGF therapy: implications for scheduling of anti-angiogenic drugs

…, NH Hendrikse, J Eriksson, AD Windhorst, PE Postmus… - Cancer cell, 2012 - cell.com
Current strategies combining anti-angiogenic drugs with chemotherapy provide clinical
benefit in cancer patients. It is assumed that anti-angiogenic drugs, such as bevacizumab, …